facebookinstagramlinkedin

A new database for biological variability was introduced

Dear members,

The database, produced by the EFLM WG “Biological Variation” (Chair: Aasne Karine Aarsand) and the EFLM TG “Biological Variation Database” (Chair: Sverre Sandberg) was launched at the EuroMedLab Congress in Barcelona.

The database, available via EFLM homepage or directly at https://biologicalvariation.eu, delivers updated evidence-based biological variation (BV) estimates to users worldwide.

Abstract:
BV data are reference data that have many applications in laboratory medicine. The data describe the variability of clinically important measurands around homeostatic set points within subjects (CVI) and between subjects (CVG). The availability of well characterised data enables the interpretation of laboratory results in clinical settings and can be used to define analytical performance specifications (APS) and other applications. The literature describing studies of BV stretches back over 45 years. Reviews of BV data identify widely varying estimates for many measurands, calling for a new approach to deliver robust BV estimates for safe clinical application. On this background, the Working Group on BV and the Task Group on the Biological Variation Database have developed a standard for evaluating studies on BV; the Biological Variation Data Critical Appraisal Checklist (BIVAC), a Minimum Dataset for BV studies and a meta-analysis approach for delivery of global BV estimates. These tools are used to populate the EFLM Biological Variation Database.

Committee for information and public relations

New EFLM webinar: „Monitoring of Internal Quality Control System Using Patient's Data”

Dear members,

we invite you to participate in EFLM webinar by EFLM WG Distance Education and e-Learning “Monitoring of Internal Quality Control System Using Patient’s Data” which will be held by Professor of Clinical Biochemistry, Abdurrahman Coskun (University of Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey on 18th of June at 6 PM.

Please find more information about this webinar: https://elearning.eflm.eu/
Registration at: https://elearning.eflm.eu/enrol/index.php?id=40
The participation is free of charge.

Committee for information and public relations

Call for nominations for the EFLM Working Group (“Distance Education and e-Learning”

Dear members,

We forward You this call for nominations of a new member for 2 years (2019-2020) for the EFLM Working Group (“Distance Education and e-Learning” (WG-DE) under the chairmanship of Prof. Darko Cerne.

More information about this WG can be found in this attachment file, as the Application form.

For the recommendation letter from HDMBLM it is neccessary to fill out the Application form and submit Your CV and list of relevant publications.

In case of more than one applicant, HDMBLM Chair committe will decide which candidate will get the recommendation letter and send the application.

Application and needed documents must be sent until 1st of June 2019 to dr. sc. Jasna Leniček Krleža: This email address is being protected from spambots. You need JavaScript enabled to view it. .

Committee for information and public relations

Call for public discussion on Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Dear members,

we wish to invite you to take part in the final stage of the development of the Joint EAS-EFLM consensus-based recommendations on quantifying atherogenic lipoproteins for lipid-lowering strategies prepared by the WG-Guidelines (attachment and attachment).

All members can send their comments and opinions (in English) to dr. sc. Jasna Leniček Krleža: This email address is being protected from spambots. You need JavaScript enabled to view it. until 15th of June 2019.

Committee for information and public relations

Send us an e-mail!

Contact

  • Croatian Society of Medical Biochemistry and Laboratory Medicine
     
    Boškovićeva 18, 10000 Zagreb
    Tel: +385 1 4828 133
    E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.